ArticleCureus2025
A Case of Complete Epithelialization of an Extensive Foot Wound With Exposed Calcaneus Using Topical Cadexomer Iodine (CIOD) Monotherapy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Managing extensive chronic foot wounds with underlying bone exposure is challenging, particularly in patients who are poor candidates for extensive surgery. Cadexomer iodine (CIOD) is a hydrophilic, sustained-release topical antimicrobial agent that has demonstrated efficacy in reducing bioburden, disrupting biofilms, and promoting autolytic debridement in chronic ulcers. To date, several reports have described epithelialization of small ulcers using CIOD alone, and others have documented epithelialization of larger ulcers when CIOD was combined with surgical procedures. However, no reports of complete epithelialization of large debrided wounds exposing bone with CIOD alone have been published. Herein, we report a case of complete epithelialization of a large debrided wound achieved with topical CIOD. This case highlights the potential utility of CIOD monotherapy for limb preservation through its sustained antimicrobial activity, inhibition of biofilm formation, control of exudate, and facilitation of autolytic debridement in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.